Results 51 to 60 of about 67,776 (202)

Characteristics of psychiatric inpatients diagnosed with mental and behavioral disorders caused by psychoactive substances (F11-19 block), with a focus on NPS and psychiatric co-morbidities

open access: yesInternational Journal of Occupational Medicine and Environmental Health, 2020
Objectives This study analyzed the prevalence of new psychoactive substance (NPS) use in the analyzed group and compared demographic features and psychoactive substance profiles between the 2 subgroups (NPS users, non-NPS users).
Piotr Engelgardt   +5 more
doaj   +1 more source

Has the COVID-19 pandemic changed substance use patterns, drug market and drug response in Poland?

open access: yesJournal of Geography, Politics and Society, 2022
The aim of this paper is to examine the impact of COVID-19 on the prevalence of substance use. Moreover, the analysis will focus on the impact of the pandemic on the drug market and drug-related crime in Poland.
Artur Malczewski   +2 more
doaj   +1 more source

Octodrine: New Questions and Challenges in Sport Supplements [PDF]

open access: yes, 2018
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).Background: Octodrine is the
Ademiluyi   +21 more
core   +3 more sources

New psychoactive substances in Vojvodina

open access: yes, 2023
The term “new psychoactive substances” (NPAS) refers to recently abused psychotropic substances that are not covered by the 1961 Convention on Narcotic Drugs and the 1971 Convention on Psychotropic Substances, but may pose a threat to public health comparable to the threat posed by classic controlled psychoactive substances. The past decade has shown a
Mijatović Jovin, Vesna   +3 more
openaire   +1 more source

The involvement of nurses and midwives in screening and brief interventions for hazardous and harmful use of alcohol and other psychoactive substances [PDF]

open access: yes, 2010
This report provides details of a review of the literature on the involvement of nurses and midwives in screening and brief interventions for hazardous and harmful use of alcohol and other psychoactive ...
Godwin, Jon   +4 more
core   +1 more source

Psychoactive Substance Use Disorder in HIV-Infected Adolescents in Botswana: A Comparison Between the Congenitally Infected and Behaviorally Infected Adolescents

open access: yesSubstance Abuse: Research and Treatment, 2023
Substance use is a major obstacle to preventing and managing HIV among adolescents, who account for 30% of new infections in many parts of the world, including Botswana. Unfortunately, there is a paucity of data on adolescent substance use, especially in
Anthony A Olashore   +3 more
doaj   +1 more source

Impact of  the  COVID-19 pandemic on substance use and dependence: new risks and challenges

open access: yesAlcoholism and Drug Addiction, 2021
The COVID-19 pandemic is a stress factor for the general population and has been associated with an increase in mental illnesses and psychoactive substance use disorders. Evidence indicates that there has been a switch in the pattern of use and choice of 
Sara Dehanov   +2 more
doaj   +1 more source

Life History Strategy and Young Adult Substance Use

open access: yesEvolutionary Psychology, 2014
This study tested whether life history strategy (LHS) and its intergenerational transmission could explain young adult use of common psychoactive substances.
George B. Richardson   +4 more
doaj   +1 more source

MDDM - New Ingredient in Ecstasy Tablets

open access: yesEmerging Trends in Drugs, Addictions, and Health
Introduction: In 2020, the first Ecstasy tablets were sent to our Institute, in which, in addition to MDMA and MDA, new psychoactive substance - MDDM (3,4-methylenedioxydimethylamphetamine) were also detected.
B. Byrska, K. Masier, R. Stanaszek
doaj   +1 more source

Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts

open access: yesFrontiers in Psychiatry, 2020
Background: Over the past 15 years, comparative assessments of psychoactive substance harms to both users and others have been compiled by addiction experts.
Udo Bonnet   +25 more
doaj   +1 more source

Home - About - Disclaimer - Privacy